Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Invested Capital (2016 - 2025)

Historic Invested Capital for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $6.1 million.

  • Sanara MedTech's Invested Capital fell 8454.41% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year decrease of 8454.41%. This contributed to the annual value of $39.4 million for FY2024, which is 2748.43% down from last year.
  • As of Q3 2025, Sanara MedTech's Invested Capital stood at $6.1 million, which was down 8454.41% from $35.4 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Invested Capital peaked at $54.3 million during Q4 2023, and registered a low of $6.1 million during Q3 2025.
  • In the last 5 years, Sanara MedTech's Invested Capital had a median value of $39.4 million in 2024 and averaged $38.1 million.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 48456.22% in 2021, then tumbled by 8454.41% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Invested Capital stood at $30.6 million in 2021, then skyrocketed by 36.16% to $41.7 million in 2022, then surged by 30.24% to $54.3 million in 2023, then fell by 27.48% to $39.4 million in 2024, then plummeted by 84.39% to $6.1 million in 2025.
  • Its Invested Capital stands at $6.1 million for Q3 2025, versus $35.4 million for Q2 2025 and $36.7 million for Q1 2025.